| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Emmaus Life Sciences, Inc. | Director | Common stock, $0.001 par value | 4,768,817 | $238,441 | $0.0500 | 15 Dec 2023 | Direct |
| Emmaus Life Sciences, Inc. | Director | Common stock, $0.001 par value | 1,270,214 | $63,511 | $0.0500 | 15 Dec 2023 | By Profit Preview International Group Limited |
| Emmaus Life Sciences, Inc. | Director | Options | 100,000 | $15,000 | $0.1500 | 01 Feb 2024 | Direct |
| Emmaus Life Sciences, Inc. | Director | Convertible Promissory Note dated 2023-01-18 | 0 | $0.5000 | 18 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EMMA | Emmaus Life Sciences, Inc. | 01 Feb 2024 | 1 | +$15,000 | 4 | Director | 05 Feb 2024, 16:39 |
| EMMA | Emmaus Life Sciences, Inc. | 15 Dec 2023 | 2 | +$90,685 | 4 | Director | 19 Dec 2023, 19:40 |
| EMMA | Emmaus Life Sciences, Inc. | 18 Jan 2023 | 1 | +$1,000,000 | 4 | Director | 20 Jan 2023, 10:40 |
| EMMA | Emmaus Life Sciences, Inc. | 12 Jan 2023 | 1 | +$450,000 | 4 | Director | 17 Jan 2023, 13:35 |